I wish we had gotten rid of Marty earlier, when we still had some life in our legs. Hope Tozer is not a Trojan horse. This could get real ugly for investors and real sweet for whomever ends up owning this technology. Buying it at discount prices.
why wouldnt this be prelude to buyout? this is a bargain price to pick up this technology and become a foremost player in wound care. maybe the company Dean came from. Buy it back and bring him back to run it.
discussion and free exchange of ideas without insults striving to determine what is really going on. Some of us knew what Marty was doing and not doing. Others continued pumping sunshine. I now wonder if big corporations would be willing to send in Tozler to make sure this product does not make it.
Deerfield cares even less than Marty about shareholders. They line their pockets and step on the dead bodies of investors they have robbed
Jason Napodano, CFA @JNapodano 14h14 hours ago
I was colossally wrong on $NUOT. Aurix is a great products but CMS-CED seems to convoluted to navigate. Cash & Cap Structure are horrible.
remember being at 2 bucks. remember Jason saying this was worth over a buck. now we are under a dime. wow. and marty got rich.
my insight saw the problems none of us wanted to recognize. shareholders got shafted while some got rich. looks like they have quietly reduced the number of board members. Marty had zero concern for shareholder value. we shall see if the new regime takes steps to protect and increase shareholder value. cut in half in one day. ouch
pick of his. How long ago was he so excited about the prospects. absolutely nothing since then.
but cutting up to 30% of other work force. Guess those sales people were not performing. Along with Marty and the board.
Second Quarter and Recent Corporate Highlights
Dean Tozer appointed President and Chief Executive Officer, effective August 15, 2015
Realignment plan and work force reduction emphasize increased focus on commercial effort in the Department of Veterans Affairs (VA) while reducing overall company headcount
Company has been in contact with Deerfield Management Company, L.P. and intends to promptly engage in substantive discussions with Deerfield to modify our credit agreement to address anticipated covenant defaults
Hopefully they really did meaningful changes before this scalping
just wait ... maybe next quarter or the next
It WAS a $1.50 biotech with partnerships pending. So close to breaking out that a huge raise and bonus were given to Martin.